Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02951351 · ClinicalTrials.gov registry record · NA
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
A NA study of Pain, Postoperative and Age-related Macular Degeneration, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02951351: Completed NA study of Pain, Postoperative and Age-related Macular Degeneration, sponsored by Mayo Clinic.
NCT02951351 is a NA study of Pain, Postoperative and Age-related Macular Degeneration that has completed, run by Mayo Clinic. The registered enrollment target is 36 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02951351, a NA study of Pain, Postoperative and Age-related Macular Degeneration, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
Primary Outcome
Conjunctival samples were collected after participants received either an additional drop of proparacaine or povidone iodine. Bacterial cultures were performed from conjunctival samples by the Mayo Clinic Microbiology laboratory. Bacterial species identification was performed on any and all bacteria that grew.
Conditions Studied
Interventions
- DRUG Proparacaine
- PROCEDURE Conjunctival culture
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-10-12 |
| Est. Completion | 2018-02 |
| Phase | NA |
What the finished NCT02951351 record still lists
NCT02951351 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (87% lower).
The record links to 5 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Proparacaine is the first listed.
NCT02951351 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02951351 about?
NCT02951351 is a clinical study titled "Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections". The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
What is the current status of trial NCT02951351?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2016-10-12. Estimated completion is 2018-02.
What conditions does trial NCT02951351 study?
This clinical trial studies the following conditions: Pain, Postoperative, Age-related Macular Degeneration, Diabetic Macular Edema, Injection Site Infection, Injection Site.
What interventions are being tested in trial NCT02951351?
The interventions under investigation include: Proparacaine (DRUG), Conjunctival culture (PROCEDURE).
Who is sponsoring clinical trial NCT02951351?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02951351 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02951351's enrollment target sits among peer trials
36 100th of 113 higher than 13 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
RECRUITING · NA
-
Dance Study for Post-surgical Pain in Breast Cancer Survivors
RECRUITING · NA
-
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
RECRUITING · NA
-
Anesthetic Optimization in Pediatric LeFort Surgeries
RECRUITING · NA
-
Latinx Children and Surgery
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI